Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk o...
Gespeichert in:
Veröffentlicht in: | Primary care diabetes 2010-10, Vol.4 (3), p.129-137 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 137 |
---|---|
container_issue | 3 |
container_start_page | 129 |
container_title | Primary care diabetes |
container_volume | 4 |
creator | Ahmed, Mohamed H Abu, Emmanuel O Byrne, Christopher D |
description | Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes. |
doi_str_mv | 10.1016/j.pcd.2010.02.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755404566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1751991810000306</els_id><sourcerecordid>755404566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-748c8e8e87071893d702671bdf1c8adc334ac99e659ce9f93c63ec46b9c897d43</originalsourceid><addsrcrecordid>eNp9kcGO0zAQhiMEYpeFB-CCfAMOKXacxDErgapdCkhVOQBnyx1PNi5uHGxnUU-8Oi5dOHDAPtgjff9I801RPGV0wShrX-0WE5hFRXNNqwWl9b3inHWiK2nF6P38Fw0rpWTdWfEoxh2lLeOdeFicVbSSspL1efFz48dy6cAP3lkgK53SgaztLQZybSPqiOTFZrlaX798TTb4g8CgncPxBknvA7nBEYN2ZAoakk3W5zISPRpi95MPSY-JbOdgcPyND6hdGoie0-BDxjG-fVw86LWL-OTuvSi-rt59ufpQrj-9_3i1XJdQC55KUXfQYb6CCtZJbgStWsG2pmfQaQOc1xqkxLaRgLKXHFqOULdbCZ0UpuYXxfNT3yn47zPGpPY2AjqnR_RzVKJpalo3bZtJdiIh-BgD9moKdq_DQTGqjtrVTmXt6qhd0Upl7Tnz7K77vN2j-Zv44zkDlycA84y3FoOKYHEENDYgJGW8_W_7N_-kwdnRgnbf8IBx5-cwZnmKqZgD6vNx78e1M5oPpy3_BXnTqC4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755404566</pqid></control><display><type>article</type><title>Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ahmed, Mohamed H ; Abu, Emmanuel O ; Byrne, Christopher D</creator><creatorcontrib>Ahmed, Mohamed H ; Abu, Emmanuel O ; Byrne, Christopher D</creatorcontrib><description>Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes.</description><identifier>ISSN: 1751-9918</identifier><identifier>EISSN: 1878-0210</identifier><identifier>DOI: 10.1016/j.pcd.2010.02.004</identifier><identifier>PMID: 20299294</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Cardiovascular diseases (CVDs) ; Cardiovascular Diseases - epidemiology ; Diabetes Mellitus, Type 2 - epidemiology ; Endocrinology & Metabolism ; Fatty Liver - diagnosis ; Fatty Liver - epidemiology ; Fatty Liver - etiology ; Fatty Liver - therapy ; General Practice - organization & administration ; Humans ; Internal Medicine ; Metabolic syndrome ; Non-alcoholic Fatty Liver Disease ; Non-alcoholic Fatty Liver Disease (NAFLD) ; Obesity - epidemiology ; Organizational Objectives ; Practice Guidelines as Topic ; Predictive Value of Tests ; Primary Health Care - organization & administration ; Prognosis ; Regional Health Planning - organization & administration ; Risk Factors</subject><ispartof>Primary care diabetes, 2010-10, Vol.4 (3), p.129-137</ispartof><rights>Primary Care Diabetes Europe</rights><rights>2010 Primary Care Diabetes Europe</rights><rights>Copyright © 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-748c8e8e87071893d702671bdf1c8adc334ac99e659ce9f93c63ec46b9c897d43</citedby><cites>FETCH-LOGICAL-c473t-748c8e8e87071893d702671bdf1c8adc334ac99e659ce9f93c63ec46b9c897d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pcd.2010.02.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20299294$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmed, Mohamed H</creatorcontrib><creatorcontrib>Abu, Emmanuel O</creatorcontrib><creatorcontrib>Byrne, Christopher D</creatorcontrib><title>Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?</title><title>Primary care diabetes</title><addtitle>Prim Care Diabetes</addtitle><description>Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes.</description><subject>Cardiovascular diseases (CVDs)</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Endocrinology & Metabolism</subject><subject>Fatty Liver - diagnosis</subject><subject>Fatty Liver - epidemiology</subject><subject>Fatty Liver - etiology</subject><subject>Fatty Liver - therapy</subject><subject>General Practice - organization & administration</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Metabolic syndrome</subject><subject>Non-alcoholic Fatty Liver Disease</subject><subject>Non-alcoholic Fatty Liver Disease (NAFLD)</subject><subject>Obesity - epidemiology</subject><subject>Organizational Objectives</subject><subject>Practice Guidelines as Topic</subject><subject>Predictive Value of Tests</subject><subject>Primary Health Care - organization & administration</subject><subject>Prognosis</subject><subject>Regional Health Planning - organization & administration</subject><subject>Risk Factors</subject><issn>1751-9918</issn><issn>1878-0210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcGO0zAQhiMEYpeFB-CCfAMOKXacxDErgapdCkhVOQBnyx1PNi5uHGxnUU-8Oi5dOHDAPtgjff9I801RPGV0wShrX-0WE5hFRXNNqwWl9b3inHWiK2nF6P38Fw0rpWTdWfEoxh2lLeOdeFicVbSSspL1efFz48dy6cAP3lkgK53SgaztLQZybSPqiOTFZrlaX798TTb4g8CgncPxBknvA7nBEYN2ZAoakk3W5zISPRpi95MPSY-JbOdgcPyND6hdGoie0-BDxjG-fVw86LWL-OTuvSi-rt59ufpQrj-9_3i1XJdQC55KUXfQYb6CCtZJbgStWsG2pmfQaQOc1xqkxLaRgLKXHFqOULdbCZ0UpuYXxfNT3yn47zPGpPY2AjqnR_RzVKJpalo3bZtJdiIh-BgD9moKdq_DQTGqjtrVTmXt6qhd0Upl7Tnz7K77vN2j-Zv44zkDlycA84y3FoOKYHEENDYgJGW8_W_7N_-kwdnRgnbf8IBx5-cwZnmKqZgD6vNx78e1M5oPpy3_BXnTqC4</recordid><startdate>20101001</startdate><enddate>20101001</enddate><creator>Ahmed, Mohamed H</creator><creator>Abu, Emmanuel O</creator><creator>Byrne, Christopher D</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101001</creationdate><title>Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?</title><author>Ahmed, Mohamed H ; Abu, Emmanuel O ; Byrne, Christopher D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-748c8e8e87071893d702671bdf1c8adc334ac99e659ce9f93c63ec46b9c897d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Cardiovascular diseases (CVDs)</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Endocrinology & Metabolism</topic><topic>Fatty Liver - diagnosis</topic><topic>Fatty Liver - epidemiology</topic><topic>Fatty Liver - etiology</topic><topic>Fatty Liver - therapy</topic><topic>General Practice - organization & administration</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Metabolic syndrome</topic><topic>Non-alcoholic Fatty Liver Disease</topic><topic>Non-alcoholic Fatty Liver Disease (NAFLD)</topic><topic>Obesity - epidemiology</topic><topic>Organizational Objectives</topic><topic>Practice Guidelines as Topic</topic><topic>Predictive Value of Tests</topic><topic>Primary Health Care - organization & administration</topic><topic>Prognosis</topic><topic>Regional Health Planning - organization & administration</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmed, Mohamed H</creatorcontrib><creatorcontrib>Abu, Emmanuel O</creatorcontrib><creatorcontrib>Byrne, Christopher D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Primary care diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmed, Mohamed H</au><au>Abu, Emmanuel O</au><au>Byrne, Christopher D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?</atitle><jtitle>Primary care diabetes</jtitle><addtitle>Prim Care Diabetes</addtitle><date>2010-10-01</date><risdate>2010</risdate><volume>4</volume><issue>3</issue><spage>129</spage><epage>137</epage><pages>129-137</pages><issn>1751-9918</issn><eissn>1878-0210</eissn><abstract>Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>20299294</pmid><doi>10.1016/j.pcd.2010.02.004</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1751-9918 |
ispartof | Primary care diabetes, 2010-10, Vol.4 (3), p.129-137 |
issn | 1751-9918 1878-0210 |
language | eng |
recordid | cdi_proquest_miscellaneous_755404566 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Cardiovascular diseases (CVDs) Cardiovascular Diseases - epidemiology Diabetes Mellitus, Type 2 - epidemiology Endocrinology & Metabolism Fatty Liver - diagnosis Fatty Liver - epidemiology Fatty Liver - etiology Fatty Liver - therapy General Practice - organization & administration Humans Internal Medicine Metabolic syndrome Non-alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease (NAFLD) Obesity - epidemiology Organizational Objectives Practice Guidelines as Topic Predictive Value of Tests Primary Health Care - organization & administration Prognosis Regional Health Planning - organization & administration Risk Factors |
title | Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A29%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-Alcoholic%20Fatty%20Liver%20Disease%20(NAFLD):%20New%20challenge%20for%20general%20practitioners%20and%20important%20burden%20for%20health%20authorities?&rft.jtitle=Primary%20care%20diabetes&rft.au=Ahmed,%20Mohamed%20H&rft.date=2010-10-01&rft.volume=4&rft.issue=3&rft.spage=129&rft.epage=137&rft.pages=129-137&rft.issn=1751-9918&rft.eissn=1878-0210&rft_id=info:doi/10.1016/j.pcd.2010.02.004&rft_dat=%3Cproquest_cross%3E755404566%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=755404566&rft_id=info:pmid/20299294&rft_els_id=1_s2_0_S1751991810000306&rfr_iscdi=true |